Metastatic Locally Advanced Small Cell Lung Cancer clinical trials

Explore recruiting metastatic locally advanced small cell lung cancer clinical trials.

Recruiting metastatic locally advanced small cell lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Locally Advanced Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2, Multicenter, Open label, Platform Study investigating Tarlatamab (AMG 757) in patients with Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), with biomarker analysis to characterize response/resistance (UNLOCK TARLATAMAB)

France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Locally Advanced Small Cell Lung Cancer trials by city

Metastatic Locally Advanced Small Cell Lung Cancer in Toronto Metastatic Locally Advanced Small Cell Lung Cancer in Vancouver Metastatic Locally Advanced Small Cell Lung Cancer in Montreal Metastatic Locally Advanced Small Cell Lung Cancer in Calgary Metastatic Locally Advanced Small Cell Lung Cancer in Edmonton Metastatic Locally Advanced Small Cell Lung Cancer in Ottawa Metastatic Locally Advanced Small Cell Lung Cancer in Winnipeg Metastatic Locally Advanced Small Cell Lung Cancer in Quebec City Metastatic Locally Advanced Small Cell Lung Cancer in Hamilton Metastatic Locally Advanced Small Cell Lung Cancer in Kitchener Metastatic Locally Advanced Small Cell Lung Cancer in London Metastatic Locally Advanced Small Cell Lung Cancer in Halifax Metastatic Locally Advanced Small Cell Lung Cancer in New York Metastatic Locally Advanced Small Cell Lung Cancer in Los Angeles Metastatic Locally Advanced Small Cell Lung Cancer in Chicago Metastatic Locally Advanced Small Cell Lung Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease